SU5416 plus hypoxia but not selective VEGFR2 inhibition with cabozantinib plus hypoxia induces pulmonary hypertension in rats: potential role of BMPR2 signaling

作者
Ravikumar A. Sitapara,Chuluunbaatar Sugarragchaa,Lawrence S. Zisman
出处
期刊:Pulmonary circulation [SAGE Publishing]
卷期号:11 (3): 1-8 被引量:9
标识
DOI:10.1177/20458940211021528
摘要

SU5416 plus chronic hypoxia causes pulmonary arterial hypertension in rats and is assumed to occur through VEGFR2 inhibition. Cabozantinib is a far more potent VEGFR2 inhibitor than SU5416. Therefore, we hypothesized that cabozantinib plus hypoxia would induce severe pulmonary arterial hypertension in rats. Cell proliferation and pharmacokinetic studies were performed. Rats were given SU5416 or cabozantinib subcutaneously or via osmotic pump and kept hypoxic for three weeks. Right ventricular systolic pressure and hypertrophy were evaluated at days 14 and 28 following removal from hypoxia. Right ventricular fibrosis was evaluated with Picro-Sirius Red staining. Kinome inhibition profiles of SU5416 and cabozantinib were performed. Inhibitor binding constants of SU5416 and cabozantinib for BMPR2 were determined and Nanostring analyses of lung mRNA were performed. Cabozantinib was a more potent VEGFR inhibitor than SU5416 and had a longer half-life in rats. Cabozantinib subcutaneous plus hypoxia did not induce severe pulmonary arterial hypertension. Right ventricular systolic pressure at 14 and 28 days post-hypoxia was 36.8 ± 2.3 mmHg and 36.2 ± 3.4 mmHg, respectively, versus 27.5 ± 1.5 mmHg in normal controls. For cabozantinib given by osmotic pump during hypoxia, right ventricular systolic pressure was 40.0 ± 3.1 mmHg at 14 days and 27.9 ± 1.9 mmHg at 28 days post-hypoxia. SU5416 plus hypoxia induced severe pulmonary arterial hypertension (right ventricular systolic pressure 61.9 ± 6.1 mmHg and 64.9 ± 8.4 mmHg at 14 and 28 days post-hypoxia, respectively). Cabozantinib induced less right ventricular hypertrophy (right ventricular free wall weight/(left ventricular free wall weight + interventricular septum weight) at 14 days post-hypoxia compared to SU5416. Right ventricular fibrosis was more extensive in the SU5416 groups compared to the cabozantinib groups. SU5416 (but not cabozantinib) inhibited BMPR2. Nanostring analyses showed effects on pulmonary gene expression of BMP10 and VEGFR1 in the SU5416 28 days post-hypoxia group. In conclusion, selective VEGFR2 inhibition using cabozantinib plus hypoxia did not induce severe pulmonary arterial hypertension. Severe pulmonary arterial hypertension due to SU5416 plus hypoxia may be due to combined VEGFR2 and BMPR2 inhibition.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
华仔的应助被褪色采纳,获得10
1秒前
Hello的应助被gina采纳,获得10
1秒前
MY完成签到,获得积分10
1秒前
2秒前
unstoppable完成签到,获得积分20
3秒前
小鹿完成签到,获得积分10
3秒前
4秒前
4秒前
乐乐的应助被假发君采纳,获得10
4秒前
yqb完成签到,获得积分10
4秒前
yuntaoZ关注了科研通微信公众号
5秒前
5秒前
闻涛发布了新的文献求助10
6秒前
田様的应助被Waitcy采纳,获得10
6秒前
7秒前
匆匆发布了新的文献求助10
7秒前
橙留香发布了新的文献求助10
7秒前
落后的语海完成签到,获得积分10
8秒前
Lazy完成签到,获得积分10
8秒前
9秒前
zdnn完成签到,获得积分10
10秒前
杨媛发布了新的文献求助10
10秒前
Livtales完成签到 ,获得积分10
11秒前
乌漆麻黑完成签到,获得积分10
11秒前
上官若男的应助被重要元灵采纳,获得10
12秒前
不灵0发布了新的文献求助10
12秒前
顾矜的应助被冰夜雨采纳,获得10
12秒前
英俊的铭的应助被脖子采纳,获得10
13秒前
怕黑的乐松完成签到,获得积分10
14秒前
li完成签到 ,获得积分10
14秒前
希望天下0贩的0的应助被rain采纳,获得10
14秒前
14秒前
casino的应助被lx采纳,获得20
14秒前
15秒前
打打的应助被小柠檬采纳,获得10
15秒前
淡淡含海发布了新的文献求助10
15秒前
经十路以东的应助被旺旺雪饼采纳,获得10
15秒前
酷波er的应助被科研通管家采纳,获得10
15秒前
领导范儿的应助被科研通管家采纳,获得10
16秒前
fan的应助被科研通管家采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193925
求助须知:如何正确求助?哪些是违规求助? 9579945
关于积分的说明 21868504
捐赠科研通 7793568
什么是DOI,文献DOI怎么找? 3437462
关于科研通互助平台的介绍 2560923
邀请新用户注册赠送积分活动 2484250